(Q35040815)

6 August 2017

1 reference

title

Tissue engineering strategies for in vivo neovascularisation (English)

1 reference

6 August 2017

1 reference

1 reference

Alessandra B Ennett

1

1 reference

6 August 2017

David J Mooney

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Expert Opinion on Biological Therapy

6 August 2017

published in

1 reference

6 August 2017

volume

2

1 reference

6 August 2017

issue

8

1 reference

6 August 2017

page(s)

805-818

1 reference

Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Endogenous angiogenesis inhibitors and their therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Hemangioblast development and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Blood vessel maturation: vascular development comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Molecular mechanisms of blood vessel growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Vascular-specific growth factors and blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Vascular morphogenesis and differentiation after adoptive transfer of human endothelial cells to immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Endothelial progenitor cells for vascular regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Origins of circulating endothelial cells and endothelial outgrowth from blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Endothelial cells derived from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Signal transduction in the control of cell growth and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Open pore biodegradable matrices formed with gas foaming

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Gene transfer for angiogenesis in coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of acidic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Gene therapy for collateral vessel development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Drug-releasing scaffolds fabricated from drug-loaded microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

DNA delivery from polymer matrices for tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Seeding of intravascular stents with genetically engineered endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Seeding of intracoronary stents with endothelial cells: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Arteriogenesis: mechanisms and modulation of collateral artery development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Serum cholesterol-lowering activity of granulocyte-macrophage colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000. American College of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Unhealthy effects of atmospheric temperature and pressure on the occurrence of myocardial infarction and coronary deaths. A 10-year survey: the Lille-World Health Organization MONICA project (Monitoring trends and determinants in cardiovascular dise

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.8.805

21 January 2018

Identifiers

DOI

10.1517/14712598.2.8.805

1 reference

6 August 2017

1 reference